{"id":2628,"date":"2023-10-10T08:00:04","date_gmt":"2023-10-10T07:00:04","guid":{"rendered":"https:\/\/www.groupactionlawyers.co.uk\/blog\/?p=2628"},"modified":"2023-08-28T14:24:03","modified_gmt":"2023-08-28T13:24:03","slug":"sabril-tablets-and-granules-concerns-raised","status":"publish","type":"post","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/sabril-tablets-and-granules-concerns-raised","title":{"rendered":"Sabril Tablets and Granules Concerns Raised"},"content":{"rendered":"

Potential concerns that have arisen regarding the potential safety of Sabril tablets and granules have been publicised by UK health regulators.<\/p>\n

The medications, manufactured by Aventis Pharma Limited (a subsidiary of Sanofi), have reportedly been subject to advice issued by The Medicines and Healthcare products Regulatory Agency (MHRA). The regulator has covered the issue of a precautionary recall for Sabril 500 mg film-coated tablets and Sabril 500 mg granules for oral solution (EL 23\/A25).<\/p>\n

<\/p>\n

The Sabril Tablets and Granules Recall<\/strong><\/h3>\n

The MHRA has publicised details about the precautionary recall of Sabril 500 mg film-coated tablets and Sabril 500 mg granules for oral solution due to: \u201cthe detection of traces of tiapride in the batches of the source material of manufacturer for vigabatrin\u201d.<\/p>\n

This deviation could impact the medication’s efficacy and potentially its safety. Patients who depend on Sabril tablets and granules for the management of conditions like epilepsy deserve medication that meets rigorous quality standards.<\/p>\n

This precautionary recall has prompted concerns over potential harm or inconvenience that may be caused by Sabril tablets and granules. Hopefully, as the publications indicate, the risks are low and no one will be harmed.<\/p>\n

Group Action Compensation: Strength in Numbers<\/strong><\/h3>\n

When multiple individuals are affected by the same issue, pursuing legal action individually can be overwhelming and less effective. A Group Action, also known as a class action lawsuit, can allow a group of people with similar claims to collectively seek compensation from the responsible party.<\/p>\n

In such cases, individuals who have experienced adverse effects or any negative impact due to such problems can join forces in a group action to maximise their chances of receiving fair compensation. Further, some cases may need to be put together in a formal Group Litigation Order (GLO) action to be able to benefit from a settlement.<\/p>\n

At The Group Action Lawyers, we specialise in representing individuals in complex cases involving defective medications and medical devices. If, for example, the Sabril tablets and granules issues result in any harm to many people, victims could theoretically form a group action case.<\/p>\n

Our experienced legal team understands the intricacies of group action lawsuits and is dedicated to helping affected individuals pursue the compensation they deserve. From gathering evidence of the impact on your health to building a robust case against a Defendant, our experts are committed to ensuring your rights are protected throughout the legal process.<\/p>\n

Claiming Group Action Compensation: Steps to Take<\/strong><\/h3>\n

Gather Information: Start by gathering all relevant information about your involvement in an issue. This could include medical records, prescription histories for medical matters, and any documentation of adverse effects or health complications.<\/p>\n

Consult Legal Experts: Reach out to The Group Action Lawyers for a free, no-obligation consultation<\/strong><\/a>. Our legal team can evaluate your case, inform you about your eligibility for a group action, and guide you through the necessary steps.<\/p>\n

Join the Group Action: If you decide to proceed, we can help you join a formal group action, which may involve combining your claim with those of other affected individuals. This collective effort enhances the strength of your case.<\/p>\n

Evidence Collection: Our legal professionals can work closely with you to gather further evidence, demonstrating the impact on you. This may involve expert medical opinions and other forms of documentation as well.<\/p>\n

Negotiation and Compensation: We can represent your interests during negotiations and fight for fair compensation on your behalf. Our goal is to ensure that your suffering and losses are acknowledged and appropriately compensated.<\/p>\n","protected":false},"excerpt":{"rendered":"

Potential concerns that have arisen regarding the potential safety of Sabril tablets and granules have been publicised by UK health regulators. The medications, manufactured by Aventis Pharma Limited (a subsidiary of Sanofi), have reportedly been subject to advice issued by The Medicines and Healthcare products Regulatory Agency (MHRA). The regulator has covered the issue of … Continue reading Sabril Tablets and Granules Concerns Raised<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":2629,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[80,36,1,5,99,27,10],"tags":[14,4,81,16,60,61,46,20,11,55,8],"class_list":["post-2628","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-group-actions","category-health","category-latest","category-medical","category-medicines","category-products","category-recalls","tag-class-actions","tag-compensation-claims","tag-group-action","tag-investigations","tag-medical-product","tag-medical-recall","tag-medicinal-drugs","tag-mhra","tag-news","tag-product-safety","tag-recalls"],"yoast_head":"\nSabril Tablets and Granules Concerns Raised - Group Action Lawyers<\/title>\n<meta name=\"description\" content=\"Potential concerns that arisen regarding the potential safety of Sabril tablets and granules have been publicised by UK health regulators.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.groupactionlawyers.co.uk\/blog\/sabril-tablets-and-granules-concerns-raised\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sabril Tablets and Granules Concerns Raised - Group Action Lawyers\" \/>\n<meta property=\"og:description\" content=\"Potential concerns that arisen regarding the potential safety of Sabril tablets and granules have been publicised by UK health regulators.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.groupactionlawyers.co.uk\/blog\/sabril-tablets-and-granules-concerns-raised\" \/>\n<meta property=\"og:site_name\" content=\"Group Action Lawyers\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-10T07:00:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/A-USED-DLL-GAL-GF-SI-MED-serious_injury-4.jpg?fit=1000%2C667&ssl=1\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"667\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Author\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Author\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/sabril-tablets-and-granules-concerns-raised#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/sabril-tablets-and-granules-concerns-raised\"},\"author\":{\"name\":\"Author\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#\\\/schema\\\/person\\\/0203ba576ea8f4e8ec318e9677b2a84b\"},\"headline\":\"Sabril Tablets and Granules Concerns Raised\",\"datePublished\":\"2023-10-10T07:00:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/sabril-tablets-and-granules-concerns-raised\"},\"wordCount\":581,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/sabril-tablets-and-granules-concerns-raised#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.groupactionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/A-USED-DLL-GAL-GF-SI-MED-serious_injury-4.jpg?fit=1000%2C667&ssl=1\",\"keywords\":[\"class actions\",\"compensation claims\",\"group action\",\"investigations\",\"medical product\",\"medical recall\",\"medicinal drugs\",\"mhra\",\"news\",\"product safety\",\"recalls\"],\"articleSection\":[\"Group Actions\",\"Health\",\"Latest\",\"Medical\",\"Medicines\",\"Products\",\"Recalls\"],\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/sabril-tablets-and-granules-concerns-raised#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/sabril-tablets-and-granules-concerns-raised\",\"url\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/sabril-tablets-and-granules-concerns-raised\",\"name\":\"Sabril Tablets and Granules Concerns Raised - Group Action Lawyers\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/sabril-tablets-and-granules-concerns-raised#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/sabril-tablets-and-granules-concerns-raised#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.groupactionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/A-USED-DLL-GAL-GF-SI-MED-serious_injury-4.jpg?fit=1000%2C667&ssl=1\",\"datePublished\":\"2023-10-10T07:00:04+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#\\\/schema\\\/person\\\/0203ba576ea8f4e8ec318e9677b2a84b\"},\"description\":\"Potential concerns that arisen regarding the potential safety of Sabril tablets and granules have been publicised by UK health regulators.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/sabril-tablets-and-granules-concerns-raised#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/sabril-tablets-and-granules-concerns-raised\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/sabril-tablets-and-granules-concerns-raised#primaryimage\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/www.groupactionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/A-USED-DLL-GAL-GF-SI-MED-serious_injury-4.jpg?fit=1000%2C667&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.groupactionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/A-USED-DLL-GAL-GF-SI-MED-serious_injury-4.jpg?fit=1000%2C667&ssl=1\",\"width\":1000,\"height\":667,\"caption\":\"Sabril tablets and granules\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/sabril-tablets-and-granules-concerns-raised#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sabril Tablets and Granules Concerns Raised\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/\",\"name\":\"Group Action Lawyers\",\"description\":\"Latest Legal News, Articles & Opinions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#\\\/schema\\\/person\\\/0203ba576ea8f4e8ec318e9677b2a84b\",\"name\":\"Author\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/538ab826f4f2d4a28667f572267412a34ffb2abdd54a9fe5d344f0d525bf201f?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/538ab826f4f2d4a28667f572267412a34ffb2abdd54a9fe5d344f0d525bf201f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/538ab826f4f2d4a28667f572267412a34ffb2abdd54a9fe5d344f0d525bf201f?s=96&d=mm&r=g\",\"caption\":\"Author\"},\"url\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/author\\\/matt\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sabril Tablets and Granules Concerns Raised - Group Action Lawyers","description":"Potential concerns that arisen regarding the potential safety of Sabril tablets and granules have been publicised by UK health regulators.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.groupactionlawyers.co.uk\/blog\/sabril-tablets-and-granules-concerns-raised","og_locale":"en_GB","og_type":"article","og_title":"Sabril Tablets and Granules Concerns Raised - Group Action Lawyers","og_description":"Potential concerns that arisen regarding the potential safety of Sabril tablets and granules have been publicised by UK health regulators.","og_url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/sabril-tablets-and-granules-concerns-raised","og_site_name":"Group Action Lawyers","article_published_time":"2023-10-10T07:00:04+00:00","og_image":[{"width":1000,"height":667,"url":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/A-USED-DLL-GAL-GF-SI-MED-serious_injury-4.jpg?fit=1000%2C667&ssl=1","type":"image\/jpeg"}],"author":"Author","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Author","Estimated reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/sabril-tablets-and-granules-concerns-raised#article","isPartOf":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/sabril-tablets-and-granules-concerns-raised"},"author":{"name":"Author","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#\/schema\/person\/0203ba576ea8f4e8ec318e9677b2a84b"},"headline":"Sabril Tablets and Granules Concerns Raised","datePublished":"2023-10-10T07:00:04+00:00","mainEntityOfPage":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/sabril-tablets-and-granules-concerns-raised"},"wordCount":581,"commentCount":0,"image":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/sabril-tablets-and-granules-concerns-raised#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/A-USED-DLL-GAL-GF-SI-MED-serious_injury-4.jpg?fit=1000%2C667&ssl=1","keywords":["class actions","compensation claims","group action","investigations","medical product","medical recall","medicinal drugs","mhra","news","product safety","recalls"],"articleSection":["Group Actions","Health","Latest","Medical","Medicines","Products","Recalls"],"inLanguage":"en-GB","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.groupactionlawyers.co.uk\/blog\/sabril-tablets-and-granules-concerns-raised#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/sabril-tablets-and-granules-concerns-raised","url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/sabril-tablets-and-granules-concerns-raised","name":"Sabril Tablets and Granules Concerns Raised - Group Action Lawyers","isPartOf":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/sabril-tablets-and-granules-concerns-raised#primaryimage"},"image":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/sabril-tablets-and-granules-concerns-raised#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/A-USED-DLL-GAL-GF-SI-MED-serious_injury-4.jpg?fit=1000%2C667&ssl=1","datePublished":"2023-10-10T07:00:04+00:00","author":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#\/schema\/person\/0203ba576ea8f4e8ec318e9677b2a84b"},"description":"Potential concerns that arisen regarding the potential safety of Sabril tablets and granules have been publicised by UK health regulators.","breadcrumb":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/sabril-tablets-and-granules-concerns-raised#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.groupactionlawyers.co.uk\/blog\/sabril-tablets-and-granules-concerns-raised"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/sabril-tablets-and-granules-concerns-raised#primaryimage","url":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/A-USED-DLL-GAL-GF-SI-MED-serious_injury-4.jpg?fit=1000%2C667&ssl=1","contentUrl":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/A-USED-DLL-GAL-GF-SI-MED-serious_injury-4.jpg?fit=1000%2C667&ssl=1","width":1000,"height":667,"caption":"Sabril tablets and granules"},{"@type":"BreadcrumbList","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/sabril-tablets-and-granules-concerns-raised#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.groupactionlawyers.co.uk\/blog"},{"@type":"ListItem","position":2,"name":"Sabril Tablets and Granules Concerns Raised"}]},{"@type":"WebSite","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#website","url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/","name":"Group Action Lawyers","description":"Latest Legal News, Articles & Opinions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.groupactionlawyers.co.uk\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#\/schema\/person\/0203ba576ea8f4e8ec318e9677b2a84b","name":"Author","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/538ab826f4f2d4a28667f572267412a34ffb2abdd54a9fe5d344f0d525bf201f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/538ab826f4f2d4a28667f572267412a34ffb2abdd54a9fe5d344f0d525bf201f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/538ab826f4f2d4a28667f572267412a34ffb2abdd54a9fe5d344f0d525bf201f?s=96&d=mm&r=g","caption":"Author"},"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/author\/matt"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/A-USED-DLL-GAL-GF-SI-MED-serious_injury-4.jpg?fit=1000%2C667&ssl=1","jetpack-related-posts":[{"id":234,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/teva-uk-ltd-has-recalled-progestogen-only-pill-drug","url_meta":{"origin":2628,"position":0},"title":"“Progestogen-only Pill Drug Recalls” – Teva UK Ltd has recalled drugs due to impurities showing in their routine testing","author":"Author","date":"17th November 2016","format":false,"excerpt":"Teva UK Limited are one of the latest pharmaceutical manufacturers that have recalled a batch of their drugs. The Nacrez 75 mg film-coated tablets have been recalled due to impurities found as part of their routine testing. The recall is said to be a precautionary measure taken by the company\u2026","rel":"","context":"In "Medical"","block_context":{"text":"Medical","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/medical"},"img":{"alt_text":"drugs","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":849,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/diclo-sr-75-pain-relief-tablets-class-2-recall","url_meta":{"origin":2628,"position":1},"title":"Class 2 recall for Diclo-SR 75 pain-relief tablets","author":"Admin","date":"28th July 2017","format":false,"excerpt":"A Watford-based pharmaceutical company has issued a voluntary recall for batches of Diclo-SR 75 pain relief tablets - AKA diclofenac sodium. The tablets are commonly used for pain relief and swelling for arthritis, musculoskeletal disorders, gout and pain caused by injury or minor surgery. The tablets are classified in a\u2026","rel":"","context":"In "Medical"","block_context":{"text":"Medical","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/medical"},"img":{"alt_text":"pain relief tablets recall","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/pain-relief-tablets-recall-min.png?fit=725%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/pain-relief-tablets-recall-min.png?fit=725%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/pain-relief-tablets-recall-min.png?fit=725%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/pain-relief-tablets-recall-min.png?fit=725%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":2698,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/in-the-news-carbomer-eye-gels-mhra-recall","url_meta":{"origin":2628,"position":2},"title":"In The News: Carbomer Eye Gels MHRA Recall","author":"Author","date":"23rd January 2024","format":false,"excerpt":"In recent publications, the MHRA has publicised a recall for specific brands of Carbomer Eye Gels due to a potential risk of infection. At The Group Action Lawyers, we understand the concerns and challenges faced by those who could be affected. This article aims to shed light on some of\u2026","rel":"","context":"In "Group Actions"","block_context":{"text":"Group Actions","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/group-actions"},"img":{"alt_text":"carbomer eye gels","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/ALSO-CEL-DBL-Lawyer-Professional-Person-Meeting-45-Copy-min.jpg?fit=695%2C509&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/ALSO-CEL-DBL-Lawyer-Professional-Person-Meeting-45-Copy-min.jpg?fit=695%2C509&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/ALSO-CEL-DBL-Lawyer-Professional-Person-Meeting-45-Copy-min.jpg?fit=695%2C509&ssl=1&resize=525%2C300 1.5x"},"classes":[]},{"id":406,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/chewy-calcium-vitamin-d-tablets-being-recalled-for-impurities","url_meta":{"origin":2628,"position":3},"title":"Chewy calcium and vitamin-D tablets are being recalled for impurities","author":"Admin","date":"28th December 2016","format":false,"excerpt":"Teva U.K. Limited - a global pharmaceutical company - has recalled a batch of class 2 medicines due to a possible metal contamination. The pharmaceutical company has recently made a precautionary batch recall for a 'small number' of Evacal D3 chewable tablets. The tablets are a calcium-vitamin D supplement used\u2026","rel":"","context":"In "Medical"","block_context":{"text":"Medical","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/medical"},"img":{"alt_text":"drugs","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":517,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/arthritis-tablets-may-adversely-affect-braille-users","url_meta":{"origin":2628,"position":4},"title":"Arthritis tablets may adversely affect users who rely solely on Braille","author":"Admin","date":"6th February 2017","format":false,"excerpt":"The Medicines and Healthcare products Regulatory Agency (MHRA) recently issued a caution relating to a drug that treats adult patients with active rheumatoid arthritis or active psoriatic arthritis. Global pharmaceutical company\u00a0Sanofi informed the medical agency of the error on the Braille on the packaging of some batches of the Arava\u2026","rel":"","context":"In "Medical"","block_context":{"text":"Medical","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/medical"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/xarelto-concerns.png?fit=725%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/xarelto-concerns.png?fit=725%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/xarelto-concerns.png?fit=725%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/xarelto-concerns.png?fit=725%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":2232,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/eye-injury-group-action-claims-for-compensation","url_meta":{"origin":2628,"position":5},"title":"Eye injury group action claims for compensation","author":"Author","date":"18th January 2022","format":false,"excerpt":"Eye injury group action cases can mean representing some of the most seriously injured people there can be when this vital sense is harmed or adversely affected by a problem. We have, and still do, represent people claiming in group\/multi-party cases for eye injury claims. If you need advice about\u2026","rel":"","context":"In "Group Actions"","block_context":{"text":"Group Actions","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/group-actions"},"img":{"alt_text":"eye compensation","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/eye-drops-recall-min.png?fit=725%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/eye-drops-recall-min.png?fit=725%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/eye-drops-recall-min.png?fit=725%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/eye-drops-recall-min.png?fit=725%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts\/2628","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/comments?post=2628"}],"version-history":[{"count":1,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts\/2628\/revisions"}],"predecessor-version":[{"id":2630,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts\/2628\/revisions\/2630"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/media\/2629"}],"wp:attachment":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/media?parent=2628"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/categories?post=2628"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/tags?post=2628"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}